Development of COVID-19 antiviral coatings for N95 respirators

开发用于 N95 呼吸器的 COVID-19 抗病毒涂层

• 批准号: 554383-2020
• 负责人: Musselman, Kevin
• 金额: $ 3.64万
• 依托单位: University of Waterloo
• 依托单位国家: 加拿大
• 项目类别: Alliance Grants
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-01-01 至 2021-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=705424
• 关键词: Development; COVID; 19; antiviral; coatings

During the outbreak of COVID-19, personal protective equipment (PPE) has played a critical role as the first line of defense between the virus and people, particularly healthcare workers. This equipment, however, is not typically treated to have antiviral properties. Since the virus is viable in aerosols and on surfaces for days, contaminated PPE has become another potential source of virus infection, posing a risk to healthcare workers and others handling the waste. In this project, antiviral coatings that are effective for COVID-19 will be developed. This will include studies on virus viability and altered protein synthesis, after exposure to different coating materials. In collaboration with Eclipse Automation, manufacturing processes will be developed to deposit these antiviral coatings on the fabrics that are employed as the outer layer on N95 respirators. The developed technology will be transferred to industry to provide enhanced PPE for Canadians.

在Covid-19的爆发期间，个人保护设备（PPE）发挥了至关重要的作用 病毒与人之间的第一道防线，尤其是医护人员。这个设备， 但是，通常不被视为具有抗病毒特性。由于该病毒在气溶胶中是可行的 几天的表面污染的PPE已成为病毒感染的另一个潜在来源，提出了A 对医疗保健工人和其他处理废物的风险。在这个项目中，将开发有效的Covid-19的抗病毒涂层。这将包括暴露于不同涂层材料后的病毒生存力和蛋白质合成改变的研究。与Eclipse自动化合作，将开发制造过程，以将这些抗病毒涂层沉积在N95呼吸器上的外层的织物上。开发的技术将转移到行业，为加拿大人提供增强的PPE。